Tuesday, August 11, 2026
11:00 am EST
Online webinar
Obesity is a complex, systems-wide disease that drives molecular changes across multiple tissues. While traditional endpoints provide important measures of efficacy, they may not fully capture the biological mechanisms underlying disease progression and therapeutic response.
Join Inotiv's Dr. Crystal West and Dr. Joshua Justice as they showcase how our DIO model can be leveraged alongside integrated proteomics, pathology, and metabolic assessment services to characterize obesity biology beyond traditional efficacy endpoints.
Topics to be covered:
- How Inotiv's DIO model recapitulates key metabolic and molecular features of human obesity
- How integrated molecular profiling reveals obesity-driven changes across skeletal muscle and other tissues
- How combining translational animal models with advanced molecular characterization can generate deeper insights into therapeutic responses
